wire report
CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens
CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, & 8230;
coverage / news / attributed
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, & 8230;
Use the references, response options, and updates before treating any contested detail as complete.
Open topic path or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to Insurance Journal’s source item, CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens, CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, …
Context
The development sits in VINI’s Markets file for readers following markets, companies, finance, insurance, public policy, and economic signals. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-06-16T05:00:59+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens via Insurance Journal. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.